W. A. Dengler

811 total citations
10 papers, 532 citations indexed

About

W. A. Dengler is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, W. A. Dengler has authored 10 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in W. A. Dengler's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Cancer Research and Treatments (2 papers). W. A. Dengler is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Cancer Research and Treatments (2 papers). W. A. Dengler collaborates with scholars based in Germany, Switzerland and United States. W. A. Dengler's co-authors include Dietmar Berger, R Mertelsmann, Johannes H. Schulte, H. H. Fiebig, Heinz‐Herbert Fiebig, H.H. Fiebig, Dieter Marmé, Heinz H. Fiebig, Joseph G. Mayo and Edward A. Sausville and has published in prestigious journals such as Annals of Oncology, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

W. A. Dengler

10 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. A. Dengler Germany	8	254	173	85	80	66	10	532
H. H. Fiebig Germany	8	229 0.9×	177 1.0×	90 1.1×	121 1.5×	50 0.8×	19	598
Peter Ward United Kingdom	13	212 0.8×	93 0.5×	61 0.7×	74 0.9×	51 0.8×	32	516
Gerd Nagel Germany	16	285 1.1×	190 1.1×	68 0.8×	49 0.6×	40 0.6×	34	675
Seung-Hee Ryu South Korea	14	300 1.2×	140 0.8×	72 0.8×	24 0.3×	81 1.2×	23	571
Sung-Won Shin South Korea	14	310 1.2×	111 0.6×	103 1.2×	27 0.3×	64 1.0×	24	553
Jeffrey R. Leipprandt United States	16	236 0.9×	116 0.7×	35 0.4×	98 1.2×	35 0.5×	21	548
Hiroyuki Kumagai Japan	15	468 1.8×	84 0.5×	76 0.9×	118 1.5×	36 0.5×	47	792
Xiaoyong Dai China	15	350 1.4×	116 0.7×	70 0.8×	42 0.5×	65 1.0×	56	620
Vincent Guerlavais United States	11	397 1.6×	214 1.2×	39 0.5×	102 1.3×	29 0.4×	22	650
Elin Lindhagen Sweden	14	245 1.0×	138 0.8×	67 0.8×	50 0.6×	35 0.5×	28	505

Countries citing papers authored by W. A. Dengler

Since Specialization

Citations

This map shows the geographic impact of W. A. Dengler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. A. Dengler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. A. Dengler more than expected).

Fields of papers citing papers by W. A. Dengler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. A. Dengler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. A. Dengler. The network helps show where W. A. Dengler may publish in the future.

Co-authorship network of co-authors of W. A. Dengler

This figure shows the co-authorship network connecting the top 25 collaborators of W. A. Dengler. A scholar is included among the top collaborators of W. A. Dengler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. A. Dengler. W. A. Dengler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Fiebig, Heinz‐Herbert, W. A. Dengler, & Hans R. Hendriks. (2000). No evidence of tumor growth stimulation in human tumors in vitro following treatment with recombinant human growth hormone. Anti-Cancer Drugs. 11(8). 659–664. 18 indexed citations

Lahn, Michael, Claudia Schmoor, W. A. Dengler, et al.. (1997). Processing of Tumor Tissues for Vaccination with Autologous Tumor Cells. European Surgical Research. 29(4). 292–302. 9 indexed citations

Groner, Bernd, Margit Jeschke, Heinz‐Herbert Fiebig, et al.. (1997). Intra-tumoral application of a heregulin-exotoxin-A fusion protein causes rapid tumor regression without adverse systemic or local effects. International Journal of Cancer. 70(6). 682–687. 8 indexed citations

Drees, Markus, W. A. Dengler, Thomas Roth, et al.. (1997). Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.. PubMed. 3(2). 273–9. 112 indexed citations

Dengler, W. A., Johannes H. Schulte, Dietmar Berger, R Mertelsmann, & H. H. Fiebig. (1995). Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anti-Cancer Drugs. 6(4). 522–532. 219 indexed citations

Berger, Dietmar, et al.. (1995). Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies. Annals of Oncology. 6(8). 817–825. 75 indexed citations

Jeschke, Margit, Winfried S. Wels, W. A. Dengler, et al.. (1995). Targeted inhibition of tumor‐cell growth by recombinant heregulin‐toxin fusion proteins. International Journal of Cancer. 60(5). 730–739. 39 indexed citations

Berger, Dietmar, U Hellerich, Sven Schulzke, et al.. (1995). Cytotoxicity of TGFα-PE40 and correlation to expression of epidermal growth factor receptor. European Journal of Cancer. 31(12). 2067–2072. 2 indexed citations

Fiebig, Heinz‐Herbert, et al.. (1992). Combined In Vitro/In Vivo Test Procedure with Human Tumor Xenografts for New Drug Development. PubMed. 165(7). 321–351. 45 indexed citations

10.

Berger, Dietmar, et al.. (1992). Preclinical activity off hepsulfam and busulfan in solid human tumor xenografts and human bone marrow. Anti-Cancer Drugs. 3(5). 531–540. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact